Add to ORKGReplicon particles of Rift Valley fever virus, referred to as nonspreading Rift Valley fever virus (NSR), are intrinsically safe and highly immunogenic. Here, we demonstrate that NSR-infected human dendritic cells can activate CD8+ T cells in vitro and that prophylactic and therapeutic vaccinations of mice with NSR encoding a tumor-associated CD8 peptide can control the outgrowth of lymphoma cells in vivo. These results suggest that the NSR system holds promise for cancer immunotherapy
ABSTRACT Efficient vaccination against infectious agents and tumors depends on specific antigen targ...
AbstractVirus-like particles (VLPs) present viral antigens in a native conformation and are effectiv...
Abstract Rift Valley fever virus (RVFV) is listed as a priority pathogen by the World Health Organiz...
Replicon particles of Rift Valley fever virus, referred to as nonspreading Rift Valley fever virus (...
Replicon particles of Rift Valley fever virus, referred to as nonspreading Rift Valley fever virus (...
Rift Valley fever virus (RVFV) is a serious pathogen for both ruminants and humans. RVF outbreaks ha...
There is no licensed human vaccine currently available for Rift Valley Fever Virus (RVFV), a Categor...
There is no licensed human vaccine currently available for Rift Valley Fever Virus (RVFV), a Categor...
<div><p>Vaccines based on nonspreading Rift Valley fever virus (NSR) induce strong humoral and robus...
Vaccines based on nonspreading Rift Valley fever virus (NSR) induce strong humoral and robust cellul...
Vaccines based on nonspreading Rift Valley fever virus (NSR) induce strong humoral and robust cellul...
Virus replicon particles are capable of infection, genome replication and gene expression, but are u...
While dendritic cell (DC) vaccines can protect hosts from tumor challenge, their ability to effectiv...
While dendritic cell (DC) vaccines can protect hosts from tumor challenge, their ability to effectiv...
AbstractRift Valley Fever virus (RVFV) regularly accounts for severe and often lethal outbreaks amon...
ABSTRACT Efficient vaccination against infectious agents and tumors depends on specific antigen targ...
AbstractVirus-like particles (VLPs) present viral antigens in a native conformation and are effectiv...
Abstract Rift Valley fever virus (RVFV) is listed as a priority pathogen by the World Health Organiz...
Replicon particles of Rift Valley fever virus, referred to as nonspreading Rift Valley fever virus (...
Replicon particles of Rift Valley fever virus, referred to as nonspreading Rift Valley fever virus (...
Rift Valley fever virus (RVFV) is a serious pathogen for both ruminants and humans. RVF outbreaks ha...
There is no licensed human vaccine currently available for Rift Valley Fever Virus (RVFV), a Categor...
There is no licensed human vaccine currently available for Rift Valley Fever Virus (RVFV), a Categor...
<div><p>Vaccines based on nonspreading Rift Valley fever virus (NSR) induce strong humoral and robus...
Vaccines based on nonspreading Rift Valley fever virus (NSR) induce strong humoral and robust cellul...
Vaccines based on nonspreading Rift Valley fever virus (NSR) induce strong humoral and robust cellul...
Virus replicon particles are capable of infection, genome replication and gene expression, but are u...
While dendritic cell (DC) vaccines can protect hosts from tumor challenge, their ability to effectiv...
While dendritic cell (DC) vaccines can protect hosts from tumor challenge, their ability to effectiv...
AbstractRift Valley Fever virus (RVFV) regularly accounts for severe and often lethal outbreaks amon...
ABSTRACT Efficient vaccination against infectious agents and tumors depends on specific antigen targ...
AbstractVirus-like particles (VLPs) present viral antigens in a native conformation and are effectiv...
Abstract Rift Valley fever virus (RVFV) is listed as a priority pathogen by the World Health Organiz...